Cooper named director of center for primary immunodeficiencies
Newly established Jeffrey Modell Diagnostic and Research Center is at SLCH
Tim MudrovicThe Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies recently was dedicated at St. Louis Children's Hospital. Pictured at the dedication are (from left) Malcolm Berry, chief development officer of the SLCH Foundation; Jeffrey and Vicki Modell; SLCH President Joan Magruder; Megan Cooper, MD, PhD; and Gary Silverman, MD, head of the Department of Pediatrics at Washington University.
Megan Cooper, MD, PhD, an assistant professor of pediatrics and of pathology and immunology at Washington University School of Medicine in St. Louis, has been named director of the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies at St. Louis Children’s Hospital.
Cooper will use resources provided by the center to improve the availability of diagnostic testing and novel targeted therapies for children with primary immunodeficiencies (PIs). She and her team also will seek to increase awareness about PIs by working to educate residents, fellows and medical peers.
PIs include a group of more than 350 genetic disorders of the immune system. They affect at least 1 in 500 people, most frequently occur in children and can be fatal if not diagnosed and treated early.
The newly named center adds St. Louis Children’s and Washington University to the Jeffrey Modell Centers Network. To read about the center and the Jeffrey Modell Foundation, see this news release.
